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Abstract
Background and Purpose—We aimed to examine perfusion changes between 3 and 6, and 6 
and 24 hours after stroke onset and their impact on tissue outcome.
Methods—Acute ischemic stroke patients underwent perfusion MRI at 3, 6, and 24hr after stroke 
onset and follow-up FLAIR at 1 month to assess tissue fate. Mean transit time prolongation maps 
(MTTp = MTT–[median MTT of contralateral hemisphere]) were obtained at 3hr (MTTp3hr), 6hr 
(MTTp6hr) and 24hr (MTTp24hr). Perfusion changes between 3– 6hrs (ΔMTTp3_6) and 6– 24hrs 
(ΔMTTp3_6) were calculated. A 2-step analysis was performed to evaluate the impact of 
ΔMTTp3_6 and ΔMTTp6_24 on tissue fate. First, a voxel-based multivariable logistic regression 
was performed for each individual patient with MTTp3hr, ΔMTTp3_6, and ΔMTT6_24 as 
independent variables and tissue fate as outcome. Second, Wilcoxon signed-rank tests on logistic 
regression coefficients were performed across patients to evaluate whether ΔMTTp3_6 and 
ΔMTT6_24 had significant impact on tissue fate for varying severities of baseline perfusion.
Results—Perfusion change was common during both time periods: 85% and 81% of patients had 
perfusion improvement during 3–6hr and 6–24hr time intervals, respectively. ΔMTT3_6 
significantly influenced 1 month infarct probability across a wide range of baseline perfusion 
(MTTp 0–15s). ΔMTT6_24 also impacted 1 month infarct probability, but its influence was 
restricted to tissue with milder baseline ischemia (MTTp 0–10s).
Conclusions—Brain tissue with mild to moderate ischemia can be salvaged by reperfusion even 
after 6 hours. Such tissue could be targeted for intervention beyond current treatment windows.
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Introduction
Pooled data from clinical trials including several thousand patients demonstrate the time-
dependence of reperfusion-promoting therapies for enhancing favorable outcomes in acute 
ischemic stroke.1, 2 For intravenous tPA, therapeutic benefit is lost 4.5 hours after stroke 
onset. For endovascular thrombectomy, which may achieve a higher likelihood of 
recanalization and greater tissue reperfusion, the window is extended up to six hours in 
patients with large vessel occlusion3–7.
Tissue fate, however, is influenced not only by the duration of ischemia, but also by the 
severity of ischemia. Jones et al.8 performed MCA occlusion in primates varying ischemia 
times from 15 minutes to permanent. Regional cerebral blood flow (CBF) and neurological 
deficits were correlated to final tissue outcome. When ischemic duration was < 30 minutes, 
all tissue survived, even tissue with severe CBF reduction. With permanent occlusion, the 
majority of tissue died, even tissue with mild ischemia. However, after two to three hours of 
ischemia, tissue with severely reduced in CBF (<10–12 ml/100g/min) died, while tissue with 
mild to moderate CBF reduction (12–18ml/100g/min) survived. Heiss and Rosner9 
confirmed the influence of both duration and severity of ischemia on tissue infarction by 
performing similar MCA occlusions in cats. These data suggested that the therapeutic 
window for ischemic stroke varied depending on the depth of ischemia: the window was 
short for tissue with severe ischemia, but prolonged for tissue with milder ischemia. This 
fundamental concept has not been examined in humans following acute ischemic stroke.
In this study, we performed sequential perfusion imaging at 3, 6, and 24 hours after stroke 
onset, evaluating the impact of 3–6hr and 6–24hr perfusion changes on tissue outcome and 
its dependence on baseline ischemic severity. We hypothesized that hyper-acute (between 3 
and 6 hr) reperfusion would improve tissue outcome across a wide range of ischemic 
severity; while reperfusion in the later window (6–24hr) would still influence ischemic 
tissue fate, and its impact might be limited to mild to moderate ischemia.
Methods
Patients and Inclusion Criteria
This was a prospective, observational MRI study in acute ischemic stroke patients at a large, 
urban, tertiary care referral center with institutional review board approval. After providing 
written informed consent, patients were enrolled within 4.5 hours of stroke onset based on 
pre-specified inclusion criteria: clinically-suspected acute ischemic stroke; age ≥ 18 years; 
and NIHSS ≥ 5. Exclusion criteria included bilateral strokes, infratentorial stroke, 
contraindication to MRI or MRI contrast, pregnancy, or any acute endovascular intervention 
planned. Both IV tPA-treated and untreated patients were included. The study imposed no 
delay in time-to-tPA treatment and no deviation from standard monitoring practices or 
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standard inclusion/exclusion criteria for IV tPA administration. Demographic data and past 
medical history were obtained by the research coordinator at the time of patient enrollment.
Magnetic Resonance Imaging Protocol
Patients underwent four serial MRI scans: within 4.5 hours (“3hr”), at 6 hours (“6hr”), at 24 
hours (“24hr”), and at 1 month after stroke onset, on a Siemens 3 Tesla whole body Trio 
scanner. For patients receiving IV tPA, the 3 hr scan was performed during IV tPA infusion. 
The MRI protocol included diffusion-weighted-imaging (DWI) and apparent diffusion 
coefficient (ADC) maps, FLAIR [TR/TE=10000/115 ms; inversion time = 2500 ms; 
matrix=512×416; 20 slices, slice thickness (TH)=5mm], and dynamic susceptibility contrast 
(DSC) perfusion images with 0.2ml/kg gadolinium contrast injected at 5 ml/sec (a T2*-
weighted gradient echo EPI sequence; TR/TE=1500/43ms; 14 slices, TH=5mm, zero 
interslice gap; matrix=128×128). The DSC method provided the perfusion weighted 
imaging (PWI) for calculation of cerebral blood flow (CBF) and cerebral blood volume 
(CBV) maps. Mean transit time (MTT) was calculated as CBV/CBF. Voxels within the 
proximal middle cerebral artery (MCA) of the contralateral hemisphere were manually 
chosen and the mean concentration curve of these voxels provided the arterial input function 
(AIF). A time-shift insensitive block-circulant singular value decomposition method was 
utilized to minimize effects of time lag of the AIF on perfusion measurements.10 
Measurements were normalized to the contralateral unaffected hemisphere. MR angiography 
was not performed. Six parameter rigid image registration was performed to align all images 
across all four scan time-points for each patient using FSL 3.2 (FMRIB, Oxford, UK).11 
Accuracy of image registration was evaluated by a board-certified neuroradiologist 
(K.D.V.). For delineation of the final infarct, hyperintense lesions were manually outlined 
on the 1 month FLAIR image by a board-certified vascular neurologist (A.L.F.). Each voxel 
on the 1 month FLAIR image was assigned a value of “dead” or “alive” as their final fate.
Image and Statistical Analysis
MTT prolongation (MTTp) defined as [MTT]–[median MTT of contralateral hemisphere] 
was used to represent tissue perfusion. MTTp maps were obtained at 3hr (MTTp3hr), 6hr 
(MTTp6hr) and 24hr (MTTp24hr) after stroke onset on a voxel-by-voxel basis. MTT was 
chosen over other time-based perfusion metrics because of a previous study which 
demonstrated that reperfusion as measured by MTT was most strongly associated with 
NIHSS improvement compared to Tmax or TTP.12 Furthermore, MTT is less affected by 
contrast “delay” from indirect macrovascular pathways of contrast delivery in the setting of 
large vessel stenosis.13 Perfusion changes between 3 to 6 hours and 6 to 24 hours were 
defined as ΔMTT3_6=6hr MTTp –3hr MTTp and ΔMTT6_24=24hr MTTp –6hr MTTp, 
respectively. To evaluate the impact of ΔMTT3_6 and ΔMTT6_24 on tissue fate, a two-step 
analysis was performed. The first step was voxel-based: For each patient, a multivariable 
logistic regression models was created on a voxel-by-voxel basis, as shown below:
Logit(P(tissue infarction)) = a0 + a1 · MTTp3hr + a2 · ΔMTT3_6 + a3 · ΔMTT6_24
where P(tissue infarction) is the probability of tissue infarction at one month follow-up MRI, 
baseline MTTp3hr and ΔMTT3_6 and ΔMTT6_24 are continuous independent variables. The 
MTTp3hr maps were stratified into four 5-second strata as [0–5], [5–10], [10–15], and [15–
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20]. For each patient, a logistic regression model was performed on voxels in each MTTp 
stratum to obtain a0, a1, a2, and a3. Logistic regression coefficients a2 and a3 characterize 
the impact of ΔMTT3_6 (a2) and ΔMTT6_24 (a3) on tissue fate, respectively. The second 
step (statistical analysis) was performed on a patient-by-patient basis: Wilcoxon signed-rank 
tests on a2 and a3 (derived from the step 1) were performed across patients to evaluate 
whether each of these parameters was significantly different from zero. Multiple 
comparisons were adjusted using a false discovery rate (FDR) of 5%. P values < 0.05 are 
considered statistically significant.
To directly visualize the impact of perfusion changes during 3 to 6 and 6 to 24 hr epochs on 
tissue fate, two three-dimensional color plots were generated to demonstrate infarct 
probability (in-plane color axis) as a function of 3hr MTTp (x-axis) and 6hr MTTp (y-axis) 
and as a function of 6hr MTTp (x-axis) and 24hr MTTp (y-axis). Infarct probabilities (IP) 
within each tissue group were defined as: IP= [number of infarcted voxels in a tissue 
group] / [total number of voxels in a tissue group]. To assess the impact of dynamic 
perfusion on the evolving ADC lesion, three-dimensional color plots were generated to 
demonstrate the percentage of voxels with “ADC positivity” (in-plane color axis) at 6hr as a 
function of 3hr MTTp (x-axis) and 6hr MTTp (y-axis), and “ADC positivity” (in-plane color 
axis) at 24hr as a function of 6hr MTTp (x-axis) and 24hr MTTp (y-axis). ADC-positivity 
was defined as a voxel with ADC < 600 mm2/sec14. Isolated regions smaller than 1 ml were 
removed from analyses to avoid inclusion of voxels with noise-induced variations.
We evaluated whether perfusion changes during the 3–6 hr or 6–24 hr epochs correlated 
with clinical outcome as measured by a change in NIHSS from 3 hours to 1 month follow-
up (ΔNIHSS3hr_1mo) or change in NIHSS from 6 hours to 1 month follow-up 
(ΔNIHSS6hr_1mo), respectively. ΔNIHSS3hr_1mo=NIHSS3hr -NIHSS1mo and 
ΔNIHSS6hr_1mo=NIHSS6hr –NIHSS1mo. Correlation between ΔNIHSS3hr_1mo and volume 
of perfusion improvement with ΔMTT improving more than 2 sec (ΔMTT3_6 <=−2 sec) 
during 3 to 6 hours in mild to severe (3< MTTp3hr ≤ 15 seconds) ischemic tissue was 
performed. In addition, correlation between ΔNIHSS6hr_1mo and volume of perfusion 
improvement with ΔMTT improving more than 2 sec (ΔMTT6_24 <=−2 sec) during 6 to 24 
hours in mild to moderate (3< MTTp3hr ≤ 10 seconds) ischemic tissue was performed.
All analyses were performed using Matlab v. 2010b (MathWorks Inc.).
Results
Twenty-seven stroke patients were imaged at a median [Interquartile range (IQR)] of 2.7 hr 
[2.3, 3.4], 6.2 hr [6.0, 6.5], 24.3 [23.8, 26.0], and 32 days [29, 35] after onset. Eighteen 
(67%) patients were treated with IV tPA. The remaining nine patients were not treated with 
IV tPA due to: current oral anticoagulant use (N=4), blood pressure > 185/110 (N=2), 
history of intracerebral hemorrhage (N=1), recent open heart surgery (N=1), and intracranial 
meningioma (N=1). Patient characteristics are shown in Table 1.
Highly dynamic perfusion during both 3–6 hr and 6–24 hr time intervals after ischemia was 
commonly observed. Of the 27 patients, 23 (85%) had perfusion improvement with ΔMTT 
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improving more than 2 sec (ΔMTT3_6 <=−2 sec) in at least 20% of baseline hypoperfused 
regions during the hyperacute phase (3–6 hrs after stroke onset); while 81% showed 
perfusion improvement (ΔMTT6_24 <=−2 sec) in the acute phase (6–24 hrs). Moreover, 16 
(59%) and 12 (44%) had at least 20% volume of perfusion deterioration with ΔMTT worse 
than 2 sec for hyperacute (ΔMTT3_6 >2 sec) and acute (ΔMTT6_24 >2 sec) time intervals, 
respectively. The absolute and percent volume of tissue showing perfusion change during 3–
6 hr and 6–24 hr intervals are shown in Fig. 1. The greatest volumes of perfusion change 
occurred in a range of ΔMTT of [−6, 6] sec during both 3–6 hr and 6–24 hr phases (Fig. 1). 
The volumes of perfusion changes were similar during the 3–6 hr and 6–24 hr epochs. Fig. 2 
shows examples of spatial and temporal perfusion changes in two acute ischemic stroke 
patients with ΔMTT overlaid onto 1 month FLAIR images during 3–6 hr (upper row) and 6–
24 hr (middle row) after ischemic onset. Patient example (A) shows greatest reperfusion 
between 3 and 6 hours after stroke onset, with little perfusion change between 6 and 24 
hours, while the patient example (B) shows the majority of reperfusion during the acute 
phase of ischemia with little change during the hyperacute phase.
The impact of ΔMTT3_6 and ΔMTT6_24 on tissue fate was evaluated using a 2-step analyses 
in each of the four MTTp3hr strata (0–5, 5–10, 10–15, and 15–20 sec). The median and IQR 
of logistic regression coefficients a2 and a3 (derived from step 1), representing coefficients 
for ΔMTT3_6 and ΔMTT6_24, respectively, across all patients are summarized in Table 2. 
After controlling for multiple comparisons using an FDR of 5%, the statistical significance 
of the Wilcoxon signed-rank tests (step 2) on a2 and a3 was also summarized in Table 2. 
Coefficients significantly different from zero indicate a significant association between the 
perfusion parameter and tissue fate at one month. ΔMTT3_6 were significantly associated 
with tissue fate for baseline MTTp3hr ranging from 0–15 sec (mild to severe ischemia); 
while ΔMTT6_24 were significantly associated with tissue fate for baseline MTTp3hr ranging 
from 0–10 sec (mild to moderate ischemia)—see table 2. Neither ΔMTT3_6 nor ΔMTT6_24 
significantly impact tissue fate in extremely severe ischemia (MTTp3hr 15–20 sec) (Table 2).
In addition to the 5 second MTTp strata, we also performed analyses using MTTp strata of 3 
and 4 second. Regardless of the strata size used, we found similar results: perfusion change 
during the hyperacute phase (3–6hrs) significantly influenced tissue fate in tissue with mild 
to severe ischemia; while perfusion change during the acute phase (6–24hr) impacted tissue 
outcome only in tissue with mild to moderate ischemia,.
To visualize the influence of perfusion changes across a wide range of baseline MTTp and 
their subsequent influence on tissue fate, 3D color plots were created to show infarct 
probability (in-plane color axis) as a function of 3hr MTTp (x-axis) and 6hr MTTp (y-axis) 
(Fig. 3A) and as a function of 6hr MTTp (x-axis) and 24hr MTTp (y-axis) (Fig. 3B). The 
fate of tissue with moderate ischemia is greatly impacted by both 3–6 hr (Fig 3a) and 6–24 
hr (Fig 3b) perfusion changes, while the fate of severely ischemic tissue was only affected 
by 3–6 hr perfusion change. Tissue with extremely severe ischemia was not impacted by 
either 3–6 hr or 6–24 hr perfusion changes (see Fig 3 legend).
During 3–6 hr, ADC lesions grow in a time-dependent manner. To evaluate how early 
perfusion changes influence the evolving ADC lesion, 3D color plots were created: the 
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percent of tissue with ADC < 600 mm2/sec at 6hr (in-plane color axis) was plotted as a 
function of 3hr MTTp (x-axis) and 6hr MTTp (y-axis) (Supplemental Figure IA) and the 
percent of tissue with ADC < 600 mm2/sec at 24hr as a function of 6hr MTTp (x-axis) and 
24hr MTTp (y-axis) (Supplemental Figure IB). ΔMTT3_6 were associated with the volume 
of ADC-positive tissue only in tissue with moderate to severe degrees of ischemia. During 
6–24 hours, only tissue with moderate ischemia showed an association between the volume 
of ADC-positive tissue and perfusion changes. These data suggest that as the ADC lesion 
grows with time, reperfusion-dependent tissue salvage (ischemic penumbra) becomes 
progressively restricted to tissues with milder ischemia.
The volume of brain tissue with perfusion improvement (defined by ΔMTT ≥2 sec between 
3 to 6 hours) was correlated to improvement in neurological deficit between 3 hours and 1 
month as measured by serial NIHSS (ΔNIHSS3hr_1mo). In tissue with mild to severe 
ischemia, the volume of brain tissue with perfusion improvement during 3–6 hrs inversely 
correlated with ΔNIHSS3hr_1mo (Fig. 4A, R=−0.48, P=0.014). Moreover, a similar inverse 
correlation was found between volume of perfusion improvement during 6–24 hrs and 
ΔNIHSS6hr_1mo in tissue with mild to moderate ischemia (Fig. 4B, R=−0.41, P=0.038). To 
verify that these results were not dependent on specific thresholds, we also used a ΔMTT 
threshold of 3 or 4 sec (ΔMTT≤-3 or -4 sec) to define perfusion improvement. Significant 
correlations remained, regardless of the ΔMTT threshold used.
Our findings demonstrated that the tissue level perfusion improvement during both 3–6 hr 
and 6–24 hr epochs was associated with clinical improvement at 1 month.
Discussion
Sequential perfusion MRI was performed at three time-points within 24 hours of stroke 
onset during which perfusion changes (both improvement and worsening) prior to and 
beyond six hours after stroke onset occurred in the majority of patients. Our key findings 
include: (1) perfusion improvement was associated with reduced infarct probability for 
tissue with mild to moderate ischemia both within and beyond six hours; (2) perfusion 
changes influenced the fate of severe ischemic tissue within but not beyond six hours; while 
(3) perfusion changes either within or beyond six hours had little impact at extremely severe 
ischemia. This data provides tissue-level evidence in ischemic stroke patients for a closing 
therapeutic window that is impacted by both time and depth of ischemia. Moreover, volume 
of tissue with perfusion improvement during both 3 to 6 hr and 6 to 24 hr epochs was 
associated with improved NIHSS at 1 month after stroke. Using color-coded duplex 
sonography to evaluate recanalization, Wunderlich et al have reported that complete 
recanalization by 30 minutes, between 30minutes to 6 hours, and between 6 to 24 hours after 
stroke onset were all significantly associated with improved 30 days functional outcome in 
99 patients.15 Our findings are consistent with this study.
Recent randomized clinical trials have demonstrated that endovascular thrombectomy 
following intravenous tPA improved recanalization of proximal artery occlusions and 
clinical outcomes compared to intravenous tPA alone3–6. In these trials, the mean time from 
symptom onset to recanalization ranged from 4.0 to 5.5 hours. Our findings suggest that 
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tissue with mild to moderate ischemia may have a prolonged therapeutic window beyond six 
hours such that a subgroup of patients may still benefit from late reperfusion-promoting 
therapies if selected properly.
Our findings in human stroke patients demonstrate that infarct probability is influenced by 
both ischemic duration and severity. Such findings are consistent with earlier blood flow 
studies in gyrencephalic animal models of focal ischemia.8, 9 While animal models of 
ischemic stroke are controlled with respect to the depth of ischemia and timing of 
reperfusion, spontaneous perfusion changes in human stroke have been poorly understood 
until recently with the advent of rapid MR and CT imaging protocols allowing for sequential 
imaging in the early hours after stroke onset. The current study measured tissue perfusion at 
three early time-points within 24 hours of stroke onset, evaluating perfusion change within 
individual voxels over time. We found that perfusion was highly dynamic during both 
hyperacute (3–6hr) and acute (6–24hr) periods. Not only did tissue demonstrate 
improvement in perfusion which was associated with lower infarct probability, but also, 
substantial tissue demonstrated worsening perfusion which was associated with higher 
infarct probability. We and other groups have previously reported on this observation of 
“worsening” or “extension” of the perfusion lesion;16–19 moreover, we previously found this 
tissue to be associated with prolonged onset-to-IV tPA-treatment, suggesting that IV tPA 
may exert its beneficial effects not only by promoting reperfusion, but also by preventing 
worsening perfusion. Our data agree with previous studies20–26 showing that, regardless of 
the time interval after stroke onset, tissue with extremely severe baseline ischemia is 
irreversibly injured.
While the present study is not able to elucidate underlying causes of perfusion instability, 
previous studies have suggested potential mechanisms leading to spontaneous reperfusion or 
worsening perfusion. Reperfusion may be related to spontaneous or therapy-induced clot 
lysis (e.g. tPA), or due to recruitment of collateral flow.27–30 Potential causes of worsening 
perfusion include: thrombus extending into a nearby branch surrounding the ischemic region 
that was not previously occluded,31 previous arterial recanalization prior to baseline imaging 
followed by re-occlusion with new ischemia on subsequent imaging,32 and loss of collateral 
flow that was supplying the territory on baseline imaging but not on subsequent imaging.30 
Peri-infarct depolarizations and cortical spreading depression may also contribute to 
worsening perfusion surrounding a region of infarction. Such depolarizations are associated 
with a progressive decline in blood flow and progressive growth in infarct.33, 3420
Our study has several strengths. It is a prospective imaging study in a cohort of ischemic 
stroke patients who were imaged at a median of 2.7 hours after stroke onset. The serial 
imaging design permitted study of dynamic perfusion changes within the first 24 hours, 
correlated with 1-month tissue outcome on a voxel-by-voxel basis (via coregistration). Study 
limitations include: (1) The sample size is small which limits the generalizability of these 
findings. (2) Discrete imaging time-points limit the knowledge of the exact timing of 
perfusion change which occurs at some time between two perfusion scans. This limits our 
knowledge of the exact therapeutic window within the time intervals that were imaged, 
especially in the 6–24 hours window. (3) Conclusions regarding the impact of dynamic 
perfusion on tissue fate are valid for perfusion changes at these two time intervals after 
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stroke onset, but will likely differ for perfusion changes at later time intervals when tissue 
fate is pre-determined. (4) This cohort included moderate to large strokes with median 
NIHSS of 16 and thus our results may not apply to patients with smaller, less severe strokes.
We did not perform MR or CT angiograph imaging in this cohort of patients. The lack of 
vascular imaging does not allow us to assess recanalization. However, it has been 
demonstrated in several studies that reperfusion is a stronger predictor of tissue fate and 
clinical outcome than recanalization.35, 36 Therefore, we think that the tissue-level 
reperfusion data is more important for our analysis than the patient-level semi-quantitative 
measures that vascular imaging provides.
These data should not be interpreted as demonstrating threshold MTTp values for baseline 
ischemia that indicate futility for reperfusion therapies. We used 5 second baseline MTTp 
strata to investigate the general physiological principle whether the impact of perfusion 
change on tissue fate during the 3 to 6 and 6 to 24 hours epochs depend on baseline tissue 
perfusion. Any MTTp thresholds derived from these or similar data would still need to be 
tested in randomized prospective study with clinical outcomes.
Conclusions
Our findings demonstrate that the fate of regions with mild to moderate ischemia is 
associated with changes in perfusion even after 6 hours and, thus, such regions may have a 
longer therapeutic window compared to regions with severe ischemia. Such tissue could be 
targeted for intervention beyond current treatment windows. Prospective randomized 
clinical trials of patients with mild to moderately ischemic tissue presenting beyond 6 hours 
are needed to determine the clinical efficacy of such an approach.
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Fig. 1. Dynamic perfusion is common during both hyperacute (3–6 hrs) and acute (6–24 hrs) 
phases of ischemic stroke
Absolute (A, C) and percent (B, D) volume with ΔMTT3_6 (upper row) and ΔMTT6_24 
(lower row) in 4 second ΔMTT increments. Data are shown as median [25th, 75th quartiles] 
across patients.
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Fig. 2. Two patient examples of spatial and temporal perfusion instability in acute ischemic 
stroke
(A) a 78 year old man with R MCA stroke, NIHSS=5, was treated with IV tPA 2.2 hr after 
onset. The first two serial perfusion imaging were obtained at 2.7 hr and 6.2 hr after onset. 
Most ischemic tissue had a perfusion improvement during the hyperacute phase (A, 1st row) 
and remained mostly stable during the acute phase (A, 2nd row). Most of the ischemic tissue 
was salvaged as a result of this hyperacute (3–6 hrs) perfusion improvement. (B) a 47 year 
old woman with R MCA stroke, NIHSS=18, was treated with IV tPA 1.7 hr after onset. The 
first two serial perfusion imaging were obtained at 2.0 hr and 6.0 hr after onset. There was a 
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small region of perfusion improvement during the hyperacute phase (B, 1st row); more 
substantial perfusion improvement occurred during the acute phase (B, 2nd row). Some but 
not all regions with the acute (6–24 hrs) perfusion improvement survived.
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Fig. 3. Dynamic perfusion changes influence tissue fate during 3–6-hour and 6–24-hour time 
interval, but the degree of tissue salvage depends on baseline severity of ischemia
3D color plots were generated to demonstrate infarct probability (in-plane color axis) as a 
function of 3hr MTTp (x-axis) and 6hr MTTp (y-axis) (A) and as a function of 6hr MTTp 
(x-axis) and 24hr MTTp (y-axis) (B). The vertical lines show how subsequent MTTp change 
may alter infarct probabilities at three given baseline MTTp (9, 15 and 19 seconds) at either 
3hrs (A) or 6hrs (B). The diagonal lines (A & B) mark stable perfusion during the 3–6 hrs 
(A) and 6–24 hrs (B) periods. Area below the diagonal line represent voxels with improved 
perfusion, while voxels below the line represent voxels with worsened prefusion. For an 
example of moderate ischemia at 3hr (MTTp of 9s, vertical line in A), if 6hr MTTp 
improved to 0–2s, infarct probability was low (~25%), however if 6hr MTTp worsened to 
17s, infarct probability was high (~85%). Using this same example of tissue with moderate 
ischemia (MTTp of 9s), infarct probability in the acute phase (6–24 hrs) (B), also varied 
greatly (from 35% to 85%), suggesting perfusion changes during this acute phase (6–24hrs) 
also influenced fate in tissue with moderate ischemia. For an example of severe ischemia 
(vertical lines crossing MTTp of 15s, A&B), infarct probability was still influenced by 
perfusion change during the hyperacute phase (3–6hrs); however, tissue fate was only 
minimally affected by perfusion change during the acute phase (6–24hr), suggesting that the 
therapeutic window for severely ischemic tissue has closed by the later time period. In tissue 
with extremely severe ischemia (MTTp of 19 seconds) infarct probability has almost no 
change in relation to perfusion changes during either the hyperacute (3–6hrs) or acute phase 
(6–24hr).
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Fig. 4. Correlation between ΔNIHSS and volume of improved perfusion between 3– 6 hours (A) 
and 6– 24 hours (B)
ΔNIHSS3hr_1mo was defined as NIHSS3hr –NIHSS1mo and ΔNIHSS6hr_1mo was defined as 
NIHSS6hr –NIHSS1mo. Volumes of improved perfusion were obtained from tissue with mild 
to severe ischemia (3<MTTp3hr≤15 seconds) at 3 hours (A) and with mild to moderate 
ischemia (3<MTTp6hr ≤10) at 6 hours (B).
An et al. Page 15
Stroke. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
An et al. Page 16
Table 1
Patient Characteristics (N=27)
Female, n (%) 8 (30%)
Age (years) 65 [55, 74]
Admission NIHSS 16 [8, 20]
African-American, n (%) 10 (37%)
tPA treatment, n (%) 18 (67%)
Admission Mean Arterial Pressure (mmHg) 114 [104, 126]
Onset to tPA treatment time 1.9 [1.7, 2.3]
Onset to 3-hr Scan, hour 2.7 [2.3, 3.4]
Onset to 6-hr Scan, hour 6.2 [6.0, 6.5]
Onset to 24-hr Scan, hour 24.3 [23.8, 26.0]
History of Hypertension, n (%) 23 (85%)
History of Diabetes, n (%) 7 (26%)
History of Congestive Heart Failure, n (%) 4 (15%)
Current Tobacco Use, n (%) 6 (22%)
History of Coronary Artery Disease, n (%) 8 (30%)
History of Stroke or TIA, n (%) 4 (15%)
Continuous data shown as median [interquartile range].
NIHSS = National Institutes of Health Stroke Scale
tp1=time-point 1 MRI; tp2=time-point 2 MRI
TIA=transient ischemic attack
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Table 2
Median and [IQR] of the logistic regressions (step 1) coefficients a2 and a3 across all patients. The statistical 
significance of the Wilcoxon signed-rank tests (step 2) on a2 and a3 were also summarized in Table 2 to 
evaluate the impact of ΔMTT3–6hr (a2) and ΔMTT6–24hr (a3) on tissue fate in each of the four MTTp strata.
MTTp strata
(seconds)
a2 (Median [IQR])
ΔMTT3–6hr
a3 (Median [IQR])
ΔMTT6–24hr
0–5 0.26 [0.11, 0.38]** 0.10 [0.04, 0.23]*
5–10 0.19 [0.06, 0.27]** 0.13 [0.05, 0.17]*
10–15 0.20 [0.04, 0.25]** 0.00 [−0.05, 0.08] (ns)
15–20 0.07 [−0.06, 0.17] (ns) −0.02 [−0.07, 0.03] (ns)
**
: P<0.001,
*
: P<0.05, ns: not significant
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